Performance of the Food and Drug...

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Eckstein, Markus, Erben, Philipp, Kriegmair, Maximilian C., Worst, Thomas S., Weiß, Cleo-Aron, Wirtz, Ralph M., Wach, Sven, Stoehr, Robert, Sikic, Danijel, Geppert, Carol I., Weyerer, Veronika, Bertz,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.11.007
Date:
January, 2019
File:
PDF, 2.57 MB
english, 2019
Conversion to is in progress
Conversion to is failed